DCF
Income statement / Annual
Last year (2024), BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.'s total revenue was $14.20 M,
a decrease of 0.19% from the previous year.
In 2024, BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.'s net income was $21.06 M.
See BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
08/31/2024 |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
| Operating Revenue |
$14.20 M
|
$14.23 M
|
-$13.29 M
|
$21.66 M
|
$1.12 M
|
$11.62 M
|
$12.03 M
|
| Cost of Revenue |
$1.62 M |
$1.63 M |
$1.95 M |
$1.90 M |
$1.71 M |
$1.78 M |
$1.60 M |
| Gross Profit |
$12.58 M |
$12.59 M |
-$15.24 M |
$19.77 M |
-$593,290.00 |
$9.84 M |
$10.43 M |
| Gross Profit Ratio |
0.89 |
0.89 |
1.15 |
0.91 |
-0.53 |
0.85 |
0.87 |
| Research and Development
Expenses |
$0.00
|
$4.03
|
-$0.85
|
$1.30
|
$16.41
|
$0.25
|
$0.40
|
| General & Administrative
Expenses |
$0.00
|
$497,751.00
|
$689,080.00
|
$624,400.00
|
$510,403.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$11.87 M
|
$497,751.00
|
$689,080.00
|
$624,400.00
|
$510,403.00
|
$0.25
|
$0.40
|
| Other Expenses |
$0.00 |
$15.06 M |
-$26.96 M |
$7.76 M |
$3.61 M |
$14.96 M |
$14.87 M |
| Operating Expenses |
$11.87 M |
$513,822.00 |
$703,377.00 |
$636,753.00 |
$524,193.00 |
$4.86 M |
$14.87 M |
| Cost And Expenses |
-$10.25 M |
$513,822.00 |
$703,377.00 |
$636,753.00 |
$524,193.00 |
$9.84 M |
$10.43 M |
| Interest Income |
$0.00 |
$14.86 M |
$11.94 M |
$12.73 M |
$12.72 M |
$14.40 M |
$0.00 |
| Interest Expense |
$0.00 |
$3.12 M |
$1.47 M |
$1.05 M |
$1.34 M |
$2.12 M |
$0.00 |
| Depreciation &
Amortization |
$0.00
|
$167,895.00
|
$228,485.00
|
$236,558.00
|
$206,297.00
|
$171,860.00
|
$0.00
|
| EBITDA |
$24.45 M
|
$13.71 M
|
-$13.99 M
|
$21.03 M
|
$597,337.00
|
$2.87 M
|
$7.19 M
|
| EBITDA Ratio |
1.72 |
0.96 |
1.05 |
0.97 |
0.53 |
0.75 |
0.6 |
| Operating Income Ratio
|
1.72
|
0.96
|
1.05
|
0.97
|
0.53
|
0.43
|
0.6
|
| Total Other
Income/Expenses Net |
-$3.39 M
|
$1.63 M
|
-$1.47 M
|
$1.90 M
|
$1.71 M
|
-$2.12 M
|
-$2.35 M
|
| Income Before Tax |
$21.06 M |
$13.71 M |
-$13.99 M |
$21.03 M |
$597,337.00 |
$2.87 M |
$7.19 M |
| Income Before Tax Ratio
|
1.48
|
0.96
|
1.05
|
0.97
|
0.53
|
0.25
|
0.6
|
| Income Tax Expense |
$0.00 |
$16.83 M |
-$12.52 M |
$22.07 M |
$1.93 M |
$0.19 |
$972,202.00 |
| Net Income |
$21.06 M |
$13.71 M |
-$13.99 M |
$21.03 M |
$597,337.00 |
$4.99 M |
$6.22 M |
| Net Income Ratio |
1.48 |
0.96 |
1.05 |
0.97 |
0.53 |
0.43 |
0.52 |
| EPS |
1.4 |
0.91 |
-0.93 |
1.4 |
0.0399 |
1.74 |
1.29 |
| EPS Diluted |
1.4 |
0.91 |
-0.93 |
1.4 |
0.0399 |
25986347 |
19116015 |
| Weighted Average Shares
Out |
$15.00 M
|
$15.00 M
|
$15.00 M
|
$14.97 M
|
$14.96 M
|
$2.87 M
|
$4.84 M
|
| Weighted Average Shares
Out Diluted |
$15.00 M
|
$15.00 M
|
$15.00 M
|
$14.97 M
|
$14.96 M
|
$0.19
|
$0.33
|
| Link |
|
|
|
|
|
|
|
